Immuno-ophthalmology
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
207
NCT05238597
A Study to Evaluate the Safety, Tolerability, and Efficacy of A197 in Subjects With Dry Eye Disease
Phase: Phase 2
Role: Lead Sponsor
Start: Jan 25, 2022
Completion: Jan 24, 2023
Loading map...